# Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis

> **NCT00552461** · PHASE2 · COMPLETED · sponsor: **East Carolina University** · enrollment: 10 (actual)

## Conditions studied

- Pulmonary Alveolar Proteinosis
- Primary Disease

## Interventions

- **DRUG:** rituximab

## Key facts

- **NCT ID:** NCT00552461
- **Lead sponsor:** East Carolina University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-07
- **Final completion:** 2011-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00552461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00552461, "Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00552461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*